These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

789 related articles for article (PubMed ID: 29383395)

  • 1. Bacterial sepsis : Diagnostics and calculated antibiotic therapy.
    Richter DC; Heininger A; Brenner T; Hochreiter M; Bernhard M; Briegel J; Dubler S; Grabein B; Hecker A; Kruger WA; Mayer K; Pletz MW; Storzinger D; Pinder N; Hoppe-Tichy T; Weiterer S; Zimmermann S; Brinkmann A; Weigand MA; Lichtenstern C
    Anaesthesist; 2019 Feb; 68(Suppl 1):40-62. PubMed ID: 29383395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bacterial sepsis : Diagnostics and calculated antibiotic therapy].
    Richter DC; Heininger A; Brenner T; Hochreiter M; Bernhard M; Briegel J; Dubler S; Grabein B; Hecker A; Krüger WA; Mayer K; Pletz MW; Störzinger D; Pinder N; Hoppe-Tichy T; Weiterer S; Zimmermann S; Brinkmann A; Weigand MA; Lichtenstern C
    Anaesthesist; 2017 Oct; 66(10):737-761. PubMed ID: 28980026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An approach to antibiotic treatment in patients with sepsis.
    Martínez ML; Plata-Menchaca EP; Ruiz-Rodríguez JC; Ferrer R
    J Thorac Dis; 2020 Mar; 12(3):1007-1021. PubMed ID: 32274170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic Stewardship and Therapeutic Drug Monitoring of β-Lactam Antibiotics: Is There a Link? An Opinion Paper.
    Richter DC; Heininger A; Chiriac U; Frey OR; Rau H; Fuchs T; Röhr AC; Brinkmann A; Weigand MA
    Ther Drug Monit; 2022 Feb; 44(1):103-111. PubMed ID: 34857694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged administration of β-lactam antibiotics - a comprehensive review and critical appraisal.
    Osthoff M; Siegemund M; Balestra G; Abdul-Aziz MH; Roberts JA
    Swiss Med Wkly; 2016; 146():w14368. PubMed ID: 27731492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic drug monitoring-guided continuous infusion of piperacillin/tazobactam significantly improves pharmacokinetic target attainment in critically ill patients: a retrospective analysis of four years of clinical experience.
    Richter DC; Frey O; Röhr A; Roberts JA; Köberer A; Fuchs T; Papadimas N; Heinzel-Gutenbrunner M; Brenner T; Lichtenstern C; Weigand MA; Brinkmann A
    Infection; 2019 Dec; 47(6):1001-1011. PubMed ID: 31473974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic drug monitoring-based dose optimisation of piperacillin/tazobactam to improve outcome in patients with sepsis (TARGET): a prospective, multi-centre, randomised controlled trial.
    Hagel S; Fiedler S; Hohn A; Brinkmann A; Frey OR; Hoyer H; Schlattmann P; Kiehntopf M; Roberts JA; Pletz MW;
    Trials; 2019 Jun; 20(1):330. PubMed ID: 31171029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic Use in the Intensive Care Unit: Optimization and De-Escalation.
    Campion M; Scully G
    J Intensive Care Med; 2018 Dec; 33(12):647-655. PubMed ID: 29534630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic treatment in patients with sepsis: a narrative review.
    Plata-Menchaca EP; Ferrer R; Ruiz Rodríguez JC; Morais R; Póvoa P
    Hosp Pract (1995); 2022 Aug; 50(3):203-213. PubMed ID: 32627615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Next-generation sequencing diagnostics of bacteremia in pediatric sepsis.
    Schmoch T; Westhoff JH; Decker SO; Skarabis A; Hoffmann GF; Dohna-Schwake C; Felderhoff-Müser U; Skolik C; Feisst M; Klose C; Bruckner T; Luntz S; Weigand MA; Sohn K; Brenner T
    Medicine (Baltimore); 2021 Jun; 100(25):e26403. PubMed ID: 34160425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapeutic drug monitoring and individual dosing of antibiotics during sepsis : Modern or just "trendy"?].
    Brinkmann A; Röhr AC; Köberer A; Fuchs T; Preisenberger J; Krüger WA; Frey OR
    Med Klin Intensivmed Notfmed; 2018 Mar; 113(2):82-93. PubMed ID: 27624768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bloodstream infections in critically ill patients: an expert statement.
    Timsit JF; Ruppé E; Barbier F; Tabah A; Bassetti M
    Intensive Care Med; 2020 Feb; 46(2):266-284. PubMed ID: 32047941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics-pharmacodynamics issues relevant for the clinical use of beta-lactam antibiotics in critically ill patients.
    Veiga RP; Paiva JA
    Crit Care; 2018 Sep; 22(1):233. PubMed ID: 30244674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Adequate anti-infective treatment : Importance of individual dosing and application].
    Brinkmann A; Röhr AC; Köberer A; Fuchs T; Krüger WA; König C; Richter D; Weigand MA; Frey OR
    Anaesthesist; 2018 Jun; 67(6):461-476. PubMed ID: 29766208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population pharmacokinetic models of first choice beta-lactam antibiotics for severe infections treatment: What antibiotic regimen to prescribe in children?
    Marsot A
    J Pharm Pharm Sci; 2020; 23():470-485. PubMed ID: 33227230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic therapy in sepsis: No next time for a second chance!
    Shahrami B; Sharif M; Sefidani Forough A; Najmeddin F; Arabzadeh AA; Mojtahedzadeh M
    J Clin Pharm Ther; 2021 Aug; 46(4):872-876. PubMed ID: 33710622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics/Pharmacodynamics of β-Lactams and Therapeutic Drug Monitoring: From Theory to Practical Issues in the Intensive Care Unit.
    Williams P; Cotta MO; Roberts JA
    Semin Respir Crit Care Med; 2019 Aug; 40(4):476-487. PubMed ID: 31585474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic aspects of beta-lactam antibiotic therapy in intensive care unit patients: A one-center experience with TDM.
    Sadilová K; Halačová M; Černý D
    Ceska Slov Farm; 2020; 69(1):17-23. PubMed ID: 32460506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of β-lactam antibiotic therapeutic drug monitoring on dose adjustments in critically ill patients undergoing continuous renal replacement therapy.
    Economou CJP; Wong G; McWhinney B; Ungerer JPJ; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2017 May; 49(5):589-594. PubMed ID: 28341612
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 40.